Geftipar 250mg Tablet

Introduction to Geftipar 250mg Tablet

Geftipar 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer cells have certain genetic mutations called EGFR mutations. This tablet is often prescribed to patients who have not undergone chemotherapy before.

Composition of Geftipar 250mg Tablet

The active ingredient in Geftipar 250mg Tablet is Gefitinib. This component works by targeting and inhibiting the activity of the EGFR tyrosine kinase, which is responsible for the growth and spread of cancer cells.

Uses of Geftipar 250mg Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftipar 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftipar 250mg Tablet

Geftipar should not be used by individuals without EGFR mutations. It is also contraindicated for pregnant or breastfeeding women, those with severe liver or kidney disease, and individuals with a history of interstitial lung disease. Patients allergic to Gefitinib or any of its ingredients should avoid this medication.

How to Take Geftipar 250mg Tablet

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Swallow the tablet whole with water, with or without food.

Conclusion of Geftipar 250mg Tablet

Geftipar 250mg Tablet is a targeted therapy for treating non-small cell lung cancer with specific genetic mutations. While it offers significant benefits, it is crucial to be aware of its side effects and take necessary precautions. Always follow your healthcare provider's instructions for optimal results.